◀ Back to FAS
FAS — PLA2G1B
Text-mined interactions from Literome
Chen et al., J Cell Biochem 2009
(Neuroblastoma) :
Deprivation of catalytic activity could not diminish
PLA(2) induced cell death and
Fas/FasL upregulation
Liu et al., J Cell Physiol 2009
(MAP Kinase Signaling System) :
Block of p38 MAPK by SB202190 abolished
PLA(2) induced
Fas/FasL upregulation and ERK inactivation, but not ROS generation ... Deprivation of catalytic activity with PLA(2) blocked completely
PLA(2) induced
Fas/FasL upregulation
Chen et al., J Cell Biochem 2009
(Calcium Signaling...) :
Unlike PLA(2), catalytically inactive PLA(2) treatment did not markedly increase Fas and FasL protein expression, and p38 MAPK activation was exclusively responsible for catalytically inactive
PLA(2) induced increase in
Fas and FasL protein expression ... Unlike arachidonic acid, lysophosphatidylcholine mimicked the
PLA(2) action in
inducing Fas/FasL upregulation ... Together with the previous finding that c-Jun and ATF-2 are involved in transcriptional regulation of Fas and FasL, our data suggest that
PLA(2) induces
Fas and FasL upregulation through p38 alpha MAPK/ATF-2 and JNK1/c-Jun pathways in K562 cells, and PLA(2) catalytic activity is involved in this action
Chen et al., J Cell Biochem 2010
(Leukemia) :
SB202190 ( p38 MAPK inhibitor ) pretreatment enhanced cytotoxic effect of PLA(2) and led to prolonged JNK activation, but failed to affect
PLA(2) induced upregulation of
Fas and FasL protein expression
Cifone et al., EMBO J 1995
(Lymphoma) :
Fas/APO-1 cross linking
resulted also in ERK-2 activation and in
phospholipase A2 (PLA2) induction, independently of the PC-PLC/aSMase pathway